APA (7th ed.) Citation

Cottu, P. H., Bonneterre, J., Varga, A., Campone, M., Leary, A., Floquet, A., . . . Italiano, A. (2018). Phase I study of onapristone, a type I antiprogestin, in female patients with previously treated recurrent or metastatic progesterone receptor-expressing cancers. PLoS ONE, 13(10), 1. https://doi.org/10.1371/journal.pone.0204973

Chicago Style (17th ed.) Citation

Cottu, Paul H., et al. "Phase I Study of Onapristone, a Type I Antiprogestin, in Female Patients with Previously Treated Recurrent or Metastatic Progesterone Receptor-expressing Cancers." PLoS ONE 13, no. 10 (2018): 1. https://doi.org/10.1371/journal.pone.0204973.

MLA (9th ed.) Citation

Cottu, Paul H., et al. "Phase I Study of Onapristone, a Type I Antiprogestin, in Female Patients with Previously Treated Recurrent or Metastatic Progesterone Receptor-expressing Cancers." PLoS ONE, vol. 13, no. 10, 2018, p. 1, https://doi.org/10.1371/journal.pone.0204973.